Results 91 to 100 of about 529,428 (208)
Peripheral targets for neuropathic pain
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour +3 more
wiley +1 more source
Background We aim to describe the evaluation and management of a patient with the uncommon combination of both mitochondrial myopathy and possible malignant hyperthermia susceptibility as an important source of information and as a valuable example of ...
Marci B. Pepper +2 more
doaj +1 more source
Recent studies demonstrate that near‐infrared (NIR—750–980 nm)‐mediated photodynamic (PDT) and photothermal (PTT) therapies, combined with metallic nanoparticles (MNPs), show promising results against skin cancer, particularly melanoma, in both in vitro and in vivo models.
Tamyris Devincenzi +3 more
wiley +1 more source
European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility [PDF]
It is 30 yr since the British Journal of Anaesthesia published the first consensus protocol for the laboratory diagnosis of malignant hyperthermia susceptibility from the European Malignant Hyperthermia Group. This has subsequently been used in more than
Girard, T. +23 more
core
Rocuronium and Malignant Hyperthermia [PDF]
Authors response to a comment on: Beggs A, McCann J, Powers J. “Delayed-onset malignant hyperthermia in association with rocuronium use ” Am J Health-Syst Pharm 2012; 69:1128 ...
Beggs, Ashton E., McCann, Jennifer Quinn
core +1 more source
Genetic Testing in Movement Disorders: Riding the Wave Without Being Swept Under
Movement Disorders, EarlyView.
Alessio Di Fonzo, Francesca Magrinelli
wiley +1 more source
Engineering Catalytic Biomaterials for Cellular Fate Modulation
Catalytic biomaterials actively reprogram cell fate by converting endogenous biochemical cues or external stimuli into localized catalytic outputs. Through regulation of redox balance, organelle homeostasis, metal‐ion metabolism, and inflammatory signaling, they bidirectionally modulate regulated cell death and immune responses for disease treatment ...
Baoying Xu +4 more
wiley +1 more source
ABSTRACT Introduction Gemtuzumab ozogamicin (GO), a CD33‐targeted antibody–drug conjugate, is approved in combination with daunorubicin/cytarabine for patients ≥ 15 years with de novo, CD33‐positive acute myeloid leukemia (AML). Methods This retrospective, observational study assessed real‐world use, clinical outcomes, and safety of GO in 113 patients ...
Juliette Lambert +8 more
wiley +1 more source
Knowledge of nursing professionals of a surgical center regarding malignant hyperthermia
The objective of this study was to assess the knowledge of the nursing professionals in a surgical center about malignant hyperthermia. This is a descriptive exploratory study on malignant hyperthermia conducted with mid- and high-level nursing ...
Cristina Silva Sousa +1 more
doaj +1 more source
Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang +16 more
wiley +1 more source

